Feature

Business-in-Brief: February 2026

  • By

  • March 5, 2026

  • 3 min

Share

Syndex Bio has secured $15.5 million in seed funding to launch its innovative methyl-copying PCR platform aimed at enhancing epigenetic diagnostics. BC Platforms has partnered with OmicsBank to expand its global data network, now covering over 187 million patients, thereby improving representation in AI drug development. In terms of product advancements, Waters introduced cybersecure automation solutions and high-sensitivity microflow columns, while SCIEX's integration of Echo MS+ offers rapid sample throughput for screening. Other firms like Bruker and Thermo Fisher have unveiled cutting-edge technologies in spatial biology and multi-omics research, respectively.

Original Source(s)

Related Content